DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award

The FY26 Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) is a funding opportunity from the Defense Health Agency, managed by the Congressionally Directed Medical Research Programs (CDMRP). It seeks applications for high-risk, high-reward research focusing on patient-centered approaches to improve health and lung cancer-related outcomes. The program will award approximately $1.95M to fund two applications, with each award capped at $975,000 over a maximum of three years. Eligibility extends to extramural and intramural U.S. Department of War organizations, including foreign and domestic, for-profit and nonprofit entities, with independent investigators as Principal Investigators. A key requirement is the inclusion of a lung cancer patient/survivor or caregiver advocate on the research team. Applications must address at least one of the FY26 LCRP Areas of Emphasis in Health Outcomes and Survivorship. The application process involves a two-step submission: a pre-application via eBRAP by August 18, 2026, and a full application via eBRAP or Grants.gov by September 2, 2026. Review criteria include research strategy, impact, patient advocate involvement, and statistical analysis, with a programmatic review also considering military health relevance. All funded projects must adhere to strict administrative and reporting requirements, including federal animal and human subjects protection regulations.